 Five metabolites (HU1 through HU5) have been described thus far.Based on the results of in vitro human hepatic cytochrome P450 studies, Remodulin does not inhibit CYP-1A2, 2C9, 2C19, 2D6, 2E1, or 3A.Whether Remodulin induces these enzymes has not been studied.